Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
2001 1
2002 1
2008 2
2009 1
2010 1
2011 1
2012 7
2013 9
2014 8
2015 10
2016 23
2017 21
2018 23
2019 20
2020 23
2021 30
2022 24
2023 23
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Results by year

Filters applied: . Clear all
Page 1
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group. D'Haens G, et al. N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940. N Engl J Med. 2023. PMID: 37379135 Clinical Trial.
Nutrition in Inflammatory Bowel Disease.
Schreiner P, Martinho-Grueber M, Studerus D, Vavricka SR, Tilg H, Biedermann L; on behalf of Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology. Schreiner P, et al. Among authors: biedermann l. Digestion. 2020;101 Suppl 1:120-135. doi: 10.1159/000505368. Epub 2020 Jan 10. Digestion. 2020. PMID: 31927540 Free article. Review.
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.
Schuppan D, Mäki M, Lundin KEA, Isola J, Friesing-Sosnik T, Taavela J, Popp A, Koskenpato J, Langhorst J, Hovde Ø, Lähdeaho ML, Fusco S, Schumann M, Török HP, Kupcinskas J, Zopf Y, Lohse AW, Scheinin M, Kull K, Biedermann L, Byrnes V, Stallmach A, Jahnsen J, Zeitz J, Mohrbacher R, Greinwald R; CEC-3 Trial Group. Schuppan D, et al. Among authors: biedermann l. N Engl J Med. 2021 Jul 1;385(1):35-45. doi: 10.1056/NEJMoa2032441. N Engl J Med. 2021. PMID: 34192430 Free article. Clinical Trial.
Reply.
Von Arnim U, Biedermann L, Bredenoord AJ. Von Arnim U, et al. Among authors: biedermann l. Clin Gastroenterol Hepatol. 2024 Jan;22(1):204. doi: 10.1016/j.cgh.2023.05.032. Epub 2023 Jun 9. Clin Gastroenterol Hepatol. 2024. PMID: 37302446 No abstract available.
Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert Recommendations.
Arnim UV, Biedermann L, Aceves SS, Bonis PA, Collins MH, Dellon ES, Furuta GT, Gonsalves N, Gupta S, Hirano I, Lucendo AJ, Miehlke S, Oliva S, Schlag C, Schoepfer A, Straumann A, Vieth M, Bredenoord AJ; EUREOS and TIGERs. Arnim UV, et al. Among authors: biedermann l. Clin Gastroenterol Hepatol. 2023 Sep;21(10):2526-2533. doi: 10.1016/j.cgh.2022.12.018. Epub 2022 Dec 24. Clin Gastroenterol Hepatol. 2023. PMID: 36572109
[Ulcerative colitis].
Roose L, D'cunja J, Biedermann L. Roose L, et al. Among authors: biedermann l. Praxis (Bern 1994). 2016 May 25;105(11):607-15. doi: 10.1024/1661-8157/a002358. Praxis (Bern 1994). 2016. PMID: 27223413 Review. German.
Editorial: anti-TNF therapy-a double-edged sword?
Schreiner P, Biedermann L. Schreiner P, et al. Among authors: biedermann l. Aliment Pharmacol Ther. 2019 Oct;50(7):822-823. doi: 10.1111/apt.15401. Aliment Pharmacol Ther. 2019. PMID: 31532545 No abstract available.
Eosinophilic esophagitis-established facts and new horizons.
Biedermann L, Straumann A, Greuter T, Schreiner P. Biedermann L, et al. Semin Immunopathol. 2021 Jun;43(3):319-335. doi: 10.1007/s00281-021-00855-y. Epub 2021 Jun 7. Semin Immunopathol. 2021. PMID: 34097125 Free PMC article. Review.
204 results